Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
E Gianchecchi, A Torelli & E Montomoli. (2019) The use of cell-mediated immunity for the evaluation of influenza vaccines: an upcoming necessity. Human Vaccines & Immunotherapeutics 15:5, pages 1021-1030.
Read now
Read now
Peter Vink, Masanari Shiramoto, Masayuki Ogawa, Masahiro Eda, Martine Douha, Thomas Heineman & Himal Lal. (2017) Safety and immunogenicity of a Herpes Zoster subunit vaccine in Japanese population aged ≥50 years when administered subcutaneously vs. intramuscularly. Human Vaccines & Immunotherapeutics 13:3, pages 574-578.
Read now
Read now
Yimei Jia, Lakshmi Krishnan & Abdelwahab Omri. (2015) Nasal and pulmonary vaccine delivery using particulate carriers. Expert Opinion on Drug Delivery 12:6, pages 993-1008.
Read now
Read now
Cécile van Els, Siri Mjaaland, Lisbeth Næss, Julia Sarkadi, Eva Gonczol, Karen Smith Korsholm, Jon Hansen, Jørgen de Jonge, Gideon Kersten, Jennifer Warner, Amanda Semper, Corine Kruiswijk & Fredrik Oftung. (2014) Fast vaccine design and development based on correlates of protection (COPs): Influenza as a trendsetter. Human Vaccines & Immunotherapeutics 10:7, pages 1935-1948.
Read now
Read now
Articles from other publishers (29)
Tiziana Ciarambino, Pietro Crispino, Pietro Buono, Vincenzo Giordano, Ugo Trama, Vincenzo Iodice, Laura Leoncini & Mauro Giordano. (2023) Efficacy and Safety of Vaccinations in Geriatric Patients: A Literature Review. Vaccines 11:9, pages 1412.
Crossref
Crossref
Debbie Duncan. (2020) Who needs a flu vaccination in 2020?. Practice Nursing 31:Sup12, pages S5-S9.
Crossref
Crossref
Nicole Baumgarth, Janko Nikolich-Žugich, F. Eun-Hyung Lee & Deepta Bhattacharya. (2020) Antibody Responses to SARS-CoV-2: Let’s Stick to Known Knowns. The Journal of Immunology 205:9, pages 2342-2350.
Crossref
Crossref
Melissa K. Andrew, Susan K. Bowles, Graham Pawelec, Laura Haynes, George A. Kuchel, Shelly A. McNeil & Janet E. McElhaney. (2018) Influenza Vaccination in Older Adults: Recent Innovations and Practical Applications. Drugs & Aging 36:1, pages 29-37.
Crossref
Crossref
Janet E. McElhaney, Melissa K. Andrew, Shelly McNeil & George A. Kuchel. 2019. Healthy Aging. Healthy Aging
181
188
.
Marie Warny, Jens Helby, Børge Grønne Nordestgaard, Henrik Birgens & Stig Egil Bojesen. (2018) Lymphopenia and risk of infection and infection-related death in 98,344 individuals from a prospective Danish population-based study. PLOS Medicine 15:11, pages e1002685.
Crossref
Crossref
Roman Chlibek, Karlis Pauksens, Lars Rombo, Gini van Rijckevorsel, Jan H. Richardus, Georg Plassmann, Tino F. Schwarz, Grégory Catteau, Himal Lal & Thomas C. Heineman. (2016) Long-term immunogenicity and safety of an investigational herpes zoster subunit vaccine in older adults. Vaccine 34:6, pages 863-868.
Crossref
Crossref
Nely Rodriguez-Zhurbenko, Maura Rabade-Chediak, Darel Martinez, Tania Griñan & Ana Maria Hernandez. (2015) Anti-NeuGcGM3 reactivity: a possible role of natural antibodies and B-1 cells in tumor immunosurveillance. Annals of the New York Academy of Sciences 1362:1, pages 224-238.
Crossref
Crossref
Robert B Couch, José M Bayas, Covadonga Caso, Innocent Nnadi Mbawuike, Concepción Núñez López, Carine Claeys, Mohamed El Idrissi, Caroline Hervé, Béatrice Laupèze, Lidia Oostvogels & Philippe Moris. (2014) Superior antigen-specific CD4+T-cell response with AS03-adjuvantation of a trivalent influenza vaccine in a randomised trial of adults aged 65 and older. BMC Infectious Diseases 14:1.
Crossref
Crossref
Kasra Moazzami, Janet E. McElhaney & Nima Rezaei. 2014. Immunology of Aging. Immunology of Aging
239
249
.
Dietmar Herndler-Brandstetter. 2014. Health and Cognition in Old Age. Health and Cognition in Old Age
55
69
.
Guro Gafvelin & Hans Grönlund. 2014. Molecular Vaccines. Molecular Vaccines
623
631
.
R. Chlibek, J. M. Bayas, H. Collins, M. L. R. de la Pinta, E. Ledent, J. F. Mols & T. C. Heineman. (2013) Safety and Immunogenicity of an AS01-adjuvanted Varicella-zoster Virus Subunit Candidate Vaccine Against Herpes Zoster in Adults >=50 Years of Age. Journal of Infectious Diseases 208:12, pages 1953-1961.
Crossref
Crossref
Hans C Rümke, Jan Hendrik Richardus, Lars Rombo, Karlis Pauksens, Georg Plaßmann, Christelle Durand, Jeanne-Marie Devaster, Walthère Dewé & Lidia Oostvogels. (2013) Selection of an adjuvant for seasonal influenza vaccine in elderly people: modelling immunogenicity from a randomized trial. BMC Infectious Diseases 13:1.
Crossref
Crossref
Larry J. Anderson. (2013) Respiratory syncytial virus vaccine development. Seminars in Immunology 25:2, pages 160-171.
Crossref
Crossref
B. J. Sedgmen, L. Papalia, L. Wang, A. R. Dyson, H. A. McCallum, C. M. Simson, M. J. Pearse, E. Maraskovsky, D. Hung, P. P. Eomois, G. Hartel, M. J. Barnden & S. P. Rockman. (2013)
Ex Vivo
Restimulation of Human PBMC Expands a
T Cell Population That Can Confound the Evaluation of CD4 and CD8 T Cell Responses to Vaccination
. Clinical and Developmental Immunology 2013, pages 1-6.
Crossref
Crossref
Julie L. Locher, Andrew C. Rucks, Sharon A. Spencer, Gregory J. Pettaway & Meredith L. Kilgore. (2012) Influenza Immunization in Older Adults with and without Cancer. Journal of the American Geriatrics Society 60:11, pages 2099-2103.
Crossref
Crossref
Isabel Leroux-Roels, Geert Leroux-Roels, Frédéric Clement, Pierre Vandepapelière, Ventzislav Vassilev, Edouard Ledent & Thomas C. Heineman. (2012) A Phase 1/2 Clinical Trial Evaluating Safety and Immunogenicity of a Varicella Zoster Glycoprotein E Subunit Vaccine Candidate in Young and Older Adults. The Journal of Infectious Diseases 206:8, pages 1280-1290.
Crossref
Crossref
P.-O. Lang. (2012) Vaccination anti-pneumococcique : état des lieux et perspectives. NPG Neurologie - Psychiatrie - Gériatrie 12:69, pages 111-120.
Crossref
Crossref
Janet E. McElhaney, Xin Zhou, H. Keipp Talbot, Ernst Soethout, R. Chris Bleackley, David J. Granville & Graham Pawelec. (2012) The unmet need in the elderly: How immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines. Vaccine 30:12, pages 2060-2067.
Crossref
Crossref
Angela W. Corona, Ashley M. Fenn & Jonathan P. Godbout. (2011) Cognitive and Behavioral Consequences of Impaired Immunoregulation in Aging. Journal of Neuroimmune Pharmacology 7:1, pages 7-23.
Crossref
Crossref
Anna Lang & Janko Nikolich-Žugich. (2011) Functional CD8 T Cell Memory Responding to Persistent Latent Infection Is Maintained for Life. The Journal of Immunology 187:7, pages 3759-3768.
Crossref
Crossref
Marcia A Blackman & David L Woodland. (2011) The narrowing of the CD8 T cell repertoire in old age. Current Opinion in Immunology 23:4, pages 537-542.
Crossref
Crossref
Janet E. McElhaney. (2011) Influenza vaccine responses in older adults. Ageing Research Reviews 10:3, pages 379-388.
Crossref
Crossref
François Roman, Frédéric Clément, Walthère Dewé, Karl Walravens, Cathy Maes, Julie Willekens, Fien De Boever, Emmanuel Hanon & Geert Leroux-Roels. (2011) Effect on Cellular and Humoral Immune Responses of the AS03 Adjuvant System in an A/H1N1/2009 Influenza Virus Vaccine Administered to Adults during Two Randomized Controlled Trials. Clinical and Vaccine Immunology 18:5, pages 835-843.
Crossref
Crossref
S. David Hudnall, Lawrence R. Stanberry & Paul D. Griffiths. 2011. Tropical Infectious Diseases: Principles, Pathogens and Practice. Tropical Infectious Diseases: Principles, Pathogens and Practice
355
368
.
Janko Nikolich-Žugich & Marcia A. Blackman. 2010. The Immune Response to Infection. The Immune Response to Infection
403
411
.
Myron J. Levin, Anne A. Gershon, Robert H. Dworkin, Marc Brisson & Lawrence Stanberry. (2010) Prevention strategies for herpes zoster and post-herpetic neuralgia. Journal of Clinical Virology 48, pages S14-S19.
Crossref
Crossref
Alexander Ademokun, Yu-Chang Wu & Deborah Dunn-Walters. (2009) The ageing B cell population: Composition and function. Biogerontology 11:2, pages 125-137.
Crossref
Crossref